156 related articles for article (PubMed ID: 9656445)
1. Type 1 and type 2 cytokines in antiviral defense.
Karupiah G
Vet Immunol Immunopathol; 1998 May; 63(1-2):105-9. PubMed ID: 9656445
[TBL] [Abstract][Full Text] [Related]
2. Polarized type 1 cytokine response and cell-mediated immunity determine genetic resistance to mousepox.
Chaudhri G; Panchanathan V; Buller RM; van den Eertwegh AJ; Claassen E; Zhou J; de Chazal R; Laman JD; Karupiah G
Proc Natl Acad Sci U S A; 2004 Jun; 101(24):9057-62. PubMed ID: 15184649
[TBL] [Abstract][Full Text] [Related]
3. Deficiency in Th2 cytokine responses exacerbate orthopoxvirus infection.
Sakala IG; Chaudhri G; Eldi P; Buller RM; Karupiah G
PLoS One; 2015; 10(3):e0118685. PubMed ID: 25751266
[TBL] [Abstract][Full Text] [Related]
4. T cell cytokine synthesis at the single-cell level in BALB/c and C57BL/6 mice infected with ectromelia virus.
Szulc L; Gieryńska M; Winnicka A; Martyniszyn L; Boratyńska-Jasińska A; Niemiałtowski M
Postepy Hig Med Dosw (Online); 2012 Apr; 66():222-30. PubMed ID: 22706108
[TBL] [Abstract][Full Text] [Related]
5. IL-12p40 and IL-18 play pivotal roles in orchestrating the cell-mediated immune response to a poxvirus infection.
Wang Y; Chaudhri G; Jackson RJ; Karupiah G
J Immunol; 2009 Sep; 183(5):3324-31. PubMed ID: 19657092
[TBL] [Abstract][Full Text] [Related]
6. The inflammatory and immune response to mousepox (infectious ectromelia) virus.
Niemiałtowski MG; Spohr de Faundez I; Gieryńska M; Malicka E; Toka FN; Schollenberger A; Popis A
Acta Virol; 1994 Oct; 38(5):299-307. PubMed ID: 7726007
[TBL] [Abstract][Full Text] [Related]
7. Expression of mouse interleukin-4 by a recombinant ectromelia virus suppresses cytolytic lymphocyte responses and overcomes genetic resistance to mousepox.
Jackson RJ; Ramsay AJ; Christensen CD; Beaton S; Hall DF; Ramshaw IA
J Virol; 2001 Feb; 75(3):1205-10. PubMed ID: 11152493
[TBL] [Abstract][Full Text] [Related]
8. Homing studies on distribution of ectromelia (mousepox) virus-specific T cells adoptively transferred into syngeneic H-2d mice: paradigm of lymphocyte migration.
Gieryńska M; Toka FN; Cespedes IS; Schollenberger A; Malicka E; Popis A; Niemiałtowski MG
Viral Immunol; 2000; 13(1):107-23. PubMed ID: 10733173
[TBL] [Abstract][Full Text] [Related]
9. Pathogenesis of mousepox in H-2(d) mice: evidence for MHC class I-restricted CD8(+) and MHC class II-restricted CD4(+) CTL antiviral activity in the lymph nodes, spleen and skin, but not in the conjunctivae.
Cespedes IS; Toka FN; Schollenberger A; Gieryńska M; Niemiałtowski M
Microbes Infect; 2001 Nov; 3(13):1063-72. PubMed ID: 11709286
[TBL] [Abstract][Full Text] [Related]
10. Oral and portal venous tolerance in the interferon-gamma knockout (GKO) mouse.
Margenthaler JA; Kataoka M; Flye WM
J Surg Res; 2004 Jun; 119(2):107-12. PubMed ID: 15145690
[TBL] [Abstract][Full Text] [Related]
11. Mousepox in inbred mice innately resistant or susceptible to lethal infection with ectromelia virus. IV. Studies with the Moscow strain.
Bhatt PN; Jacoby RO; Gras L
Arch Virol; 1988; 100(3-4):221-30. PubMed ID: 2840874
[TBL] [Abstract][Full Text] [Related]
12. Gamma interferon is not required for mucosal cytotoxic T-lymphocyte responses or heterosubtypic immunity to influenza A virus infection in mice.
Nguyen HH; van Ginkel FW; Vu HL; Novak MJ; McGhee JR; Mestecky J
J Virol; 2000 Jun; 74(12):5495-501. PubMed ID: 10823854
[TBL] [Abstract][Full Text] [Related]
13. Enhanced resistance in STAT6-deficient mice to infection with ectromelia virus.
Mahalingam S; Karupiah G; Takeda K; Akira S; Matthaei KI; Foster PS
Proc Natl Acad Sci U S A; 2001 Jun; 98(12):6812-7. PubMed ID: 11371617
[TBL] [Abstract][Full Text] [Related]
14. ECTV Abolishes the Ability of GM-BM Cells to Stimulate Allogeneic CD4 T Cells in a Mouse Strain-Independent Manner.
Szulc-Dąbrowska L; Wojtyniak P; Struzik J; Toka FN; Winnicka A; Gieryńska M
Immunol Invest; 2019 May; 48(4):392-409. PubMed ID: 30884992
[TBL] [Abstract][Full Text] [Related]
15. Characterization of T cell clones derived from lymph nodes and lungs of Pseudomonas aeruginosa-susceptible and resistant mice following immunization with heat-killed bacteria.
Kondratieva TK; Kobets NV; Khaidukov SV; Yeremeev VV; Lyadova IV; Apt AS; Tam MF; Stevenson MM
Clin Exp Immunol; 2000 Aug; 121(2):275-82. PubMed ID: 10931142
[TBL] [Abstract][Full Text] [Related]
16. Genetically resistant mice lacking interleukin-12 are susceptible to infection with Leishmania major and mount a polarized Th2 cell response.
Mattner F; Magram J; Ferrante J; Launois P; Di Padova K; Behin R; Gately MK; Louis JA; Alber G
Eur J Immunol; 1996 Jul; 26(7):1553-9. PubMed ID: 8766560
[TBL] [Abstract][Full Text] [Related]
17. Retrovirus-elicited interleukin-12 and tumour necrosis factor-alpha as inducers of interferon-gamma-mediated pathology in mouse AIDS.
Giese NA; Gazzinelli RT; Actor JK; Morawetz RA; Sarzotti M; Morse HC
Immunology; 1996 Mar; 87(3):467-74. PubMed ID: 8778035
[TBL] [Abstract][Full Text] [Related]
18. Self-priming cell culture system for monitoring genetically-controlled spontaneous cytokine-producing ability in mice.
Sato M; Iwakabe K; Ohta A; Sekimoto M; Kimura S; Nishimura T
Immunol Lett; 1999 Dec; 70(3):173-8. PubMed ID: 10656670
[TBL] [Abstract][Full Text] [Related]
19. [TH1 response in the experimental infection with Trypanosoma cruzi].
Cardoni RL; Antúnez MI; Abrami AA
Medicina (B Aires); 1999; 59 Suppl 2():84-90. PubMed ID: 10668248
[TBL] [Abstract][Full Text] [Related]
20. Protective effect of exogenous recombinant mouse interferon-gamma and tumour necrosis factor-alpha on ectromelia virus infection in susceptible BALB/c mice.
Atrasheuskaya AV; Bukin EK; Fredeking TM; Ignatyev GM
Clin Exp Immunol; 2004 May; 136(2):207-14. PubMed ID: 15086382
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
